This federal Project Grant award, funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, provides $399,999 per year for up to five years to the non-profit organization Center Point, Inc. (CPI) to expand treatment and recovery services for adult men and women with substance use disorders and/or co-occurring mental health disorders who are returning...
This $750,000 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program will enable Center Point, Inc. (CPI), a non-profit organization in San Rafael, CA, to expand and enhance its comprehensive substance use disorder (SUD) continuum of care. The funding will be used to provide job training, transitional housing/recovery residences, and...
This Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) provides $400,000 in funding to the Center for Health Justice, Inc., a Los Angeles-based non-profit organization. The project, titled "Project RENEW," aims to expand trauma-informed substance use disorder (SUD) treatment, recovery, and reentry services for 18-35...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $500,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to Erise Williams and Associates, Inc. to implement the "STL MADE: Substance Use Disorder Treatment for Racial/Ethnic Minority Populations at Risk for HIV/AIDS" project. The project aims to increase engagement in care for Black/African American individuals 18...
The U.S. Department of Health and Human Services' Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $500,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the Center for Health Justice, Inc., a Los Angeles-based non-profit organization. The grant, titled "Project HOPE," aims to implement substance use disorder (SUD) and co-occurring mental health treatment and...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $1,500,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the County of Alameda's Alameda County Health Care for the Homeless (HCH) program. The purpose of this 5-year grant is to reduce substance use-related mortality among people experiencing homelessness in Alameda County, California. The key activities to be delivered...
This $1,773,802 federal Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program will enable the Cook Inlet Tribal Council, Inc. (CITC) to expand and enhance its residential substance use disorder (SUD) and co-occurring disorder (COD) treatment and recovery services in the Anchorage, Alaska metropolitan area. Specifically, the grant will...
This Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program provides $1,500,000 to Care Plus NJ Inc. over 5 years, from September 30, 2024 to September 29, 2029. The funding will support Care Plus NJ Inc.'s "Treatment for Individuals Experiencing Homelessness" (TIEH) program, which will provide comprehensive case management...
This federal Project Grant award of $1,497,006, provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, aims to increase access to and engagement in culturally congruent substance use disorder (SUD) and co-occurring mental health disorder (COD) care for 225 racial and ethnic minority LGBTQ+ individuals in Rhode Island. The primary objectives are...
This $600,000 Project Grant award from the Health Resources and Services Administration (HRSA) under the Community Health Centers (CFDA 93.224) program aims to expand behavioral health services and substance use disorder treatment for adolescents and young adults in Oakland, California. The key products and services to be delivered include: Hiring and supporting additional licensed clinical social workers at the primary care site and school-based health centers to provide mental health...
TREATMENTLINK - CENTER POINT, INC. (CPI) IS REQUESTING $500,000 PER YEAR FOR UP TO FIVE YEARS FROM THE SAMHSA CENTER FOR SUBSTANCE ABUSE TREATMENT TO EXPAND ENGAGEMENT AND INCREASE THE AVAILABILITY OF COMPREHENSIVE RESIDENTIAL AND OUTPATIENT TREATMENT; PREVENTION; CARE; RECOVERY SUPPORT SERVICES; AND HARM REDUCTION INTERVENTIONS FOR RACIAL AND ETHNIC UNDERREPRESENTED INDIVIDUALS WITH SUD AND COD WHO ARE AT-RISK FOR, OR WHO ARE LIVING WITH HIV/AIDS. THE POPULATION OF FOCUS FOR THE TREATMENT LINK PROJECT IS LOW-INCOME AFRICAN AMERICAN AND HISPANIC/LATINO MEN AND WOMEN WHO ARE HOMELESS AND/OR WHO HAVE RELEASED FROM INCARCERATION WITHIN THE PAST YEAR AND WHO HAVE LIMITED ACCESS TO QUALITY PRIMARY AND SPECIALTY CARE OR A COMPREHENSIVE TREATMENT SERVICE SYSTEM FOR SUD AND COD. THE GEOGRAPHIC CATCHMENT AREA WHERE PROJECT SERVICES WILL BE DELIVERED IS THE SAN FRANCISCO, ALAMEDA, AND MARIN COUNTY AND THE GREATER BAY AREA, CALIFORNIA. TREATMENT LINK WILL EXPAND ACCESS AND ADMIT AN ADDITIONAL 15 PARTICIPANTS PER YEAR; A TOTAL OF 75 UNDUPLICATED PARTICIPANTS WILL BE ADMITTED TO TREATMENT LINK. THE GOALS OF TREATMENT LINK ARE TO CONDUCT OUTREACH STRATEGIES IN THE IDENTIFIED COMMUNITIES TO IDENTIFY, ENGAGE, AND ADMIT MEMBERS OF THE FOCUS POPULATION INTO RESIDENTIAL AND OUTPATIENT TREATMENT; DELIVER AN EFFECTIVE, EVIDENCE-BASED, COMPREHENSIVE SYSTEM-OF-CARE, INCLUDING TRAUMA-INFORMED SERVICE, HARM REDUCTION, AND RECOVERY SUPPORT SERVICES; IMPROVE TREATMENT AND RECOVERY OUTCOMES AND QUALITY OF LIFE FOR THOSE WITH OR AT-RISK OF HIV/AIDS AND THEIR PARTNERS; PROVIDE PRIMARY AND SPECIALTY MEDICAL, MENTAL HEALTH, VOCATIONAL, AND EDUCATIONAL PROGRAMS; AND INCREASE CPI'S SUSTAINABLE CAPACITY AND EXPAND THE AVAILABILITY OF A COMPREHENSIVE CONTINUUM OF CARE THAT PROMOTES RECOVERY AND INDEPENDENCE FOR PARTICIPANTS. CPI WILL CONDUCT COMPREHENSIVE SUD, COD, AND PHYSICAL HEALTH SCREENINGS AND ASSESSMENTS AT INTAKE AND CONTINUOUSLY TO AID IN THE DIAGNOSIS OF MEDICAL NECESSITIES, TREATMENT PLANNING AND CLINICAL NEEDS, MEDICATIONS, INCLUDING MEDICATION ASSISTED TREATMENT (MAT). CPI WILL EMBED TREATMENT LINK COMPONENTS WITHIN A COMPREHENSIVE MULTI-MODALITY SYSTEM-OF-CARE, INCLUDING CARF ACCREDITED, DHCS LICENSED AND CERTIFIED ASAM LEVELS OF CARE FOR OUTPATIENT (1.0, 2.1) AND RESIDENTIAL (3.1, 3.2WM, 3.2, 3.5), AND RECOVERY RESIDENCES. TREATMENT LINK WILL ENHANCE THE QUALITY AND INTENSITY OF INTEGRATED PRIMARY AND SPECIALTY CARE AND MENTAL HEALTH TREATMENT PROVIDED THROUGH EXPANDED CARE COORDINATION AND CASE MANAGEMENT AT CPI'S CO-LOCATED CLINIC PARTNERSHIP WITH THE MARIN COMMUNITY CLINICS, FQHC. CPI, WITH 50+ YEARS OF EXPERIENCE IN THE SF BAY AREA, WILL SERVE AS THE PRIMARY PROVIDER OF ALL SUD AND COD TREATMENT SERVICES AND WILL PROVIDE COORDINATED CARE COORDINATION AND COLLATERAL SUPPORT TO THOSE REFERRED FOR CONFIRMATORY HIV TESTING AND/OR TREATMENT.